SCHEMBL2808034

SCHEMBL2808034

COc1ccc(S(=O)(=O)NC2CCc3c(cnc4[nH]ncc34)C2)cc1OC

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 2/20 0.52
PDE4A P27815 4/20 0.51
PDE4B Q07343 4/20 0.51
PDE4C Q08493 4/20 0.51
PDE4D Q08499 4/20 0.51
ADRA1A P35348 2/20 0.45
ADRA1B P35368 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.41
GAA P10253 2/20 0.41
MAPK1 P28482 1/20 0.41
POLB P06746 1/20 0.41
ALDH1A1 P00352 2/20 0.41
HPGD P15428 1/20 0.41
HTT P42858 1/20 0.41
TP53 P04637 1/20 0.41
PKM P14618 1/20 0.41
ALOX15 P16050 1/20 0.41
KMT2A Q03164 1/20 0.41
DRD2 P14416 1/20 0.39
ADRA1D P25100 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2803976 0.87 TBXA2R (0.42) HDAC8GAAALDH1A1CA1CA2
SCHEMBL2803941 0.86 ALDH1A1 (0.49) HDAC8SMN1; SMN2GAAPOLBALDH1A1
SCHEMBL2802661 0.86 HSD11B1 (0.40) HDAC8GAACA1CA2ACHE
SCHEMBL2802855 0.85 CTSL (0.45) ADRA1AADRA1BSMN1; SMN2HTTTP53
SCHEMBL2803943 0.84 L3MBTL1 (0.41) HDAC8ADRA1AADRA1BSMN1; SMN2TP53
SCHEMBL2803517 0.84 RB1 (0.40) HDAC8SMN1; SMN2ALDH1A1KMT2ACA1
SCHEMBL2804951 0.84 ALDH1A1 (0.44) SMN1; SMN2ALDH1A1HTT
SCHEMBL12315802 0.84 FGFR1 (0.39) HDAC8GAAALDH1A1HPGDHTT
SCHEMBL2807111 0.83 KMT2A (0.50) HDAC8GAAALDH1A1HPGDHTT
SCHEMBL2808103 0.83 HDAC8 (0.49) HDAC8SMN1; SMN2MAPK1ALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8263610-B2 Substituted imidazolyl-5,6-dihydrobenzo[N]isoquinoline compounds ARQULE, INC. (US) 2012-09-11 US disclosed
US-20100239526-A1 SUBSTITUTED IMIDAZOLYL-5,6-DIHYDROBENZO[N]ISOQUINOLINE COMPOUNDS ARQULE, INC. (US) 2010-09-23 US disclosed
WO-2010078427-A1 SUBSTITUTED PYRAZOLO [3, 4-B] PYRIDINE COMPOUNDS ARQULE, INC. (US) 2010-07-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100239526-A1 SUBSTITUTED IMIDAZOLYL-5,6-DIHYDROBENZO[N]ISOQUINOLINE COMPOUNDS NQO1, IDH3B, IDH1 HDAC8 615/4885PDE4A 936/4885PDE4B 479/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.